Senestech (SNES) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Voting matters and shareholder proposals
Election of two Class I director nominees, Jake S. Leach and Joshua M. Moss, each for a three-year term ending in 2029.
Advisory vote on executive compensation for the fiscal year ended 2025 ("say-on-pay").
Approval sought for an amendment to the 2018 Equity Incentive Plan to increase available shares by 1,700,000.
Ratification of M & K CPAS, PLLC as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Additional business may be transacted as appropriate at the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all proposals, including director elections and compensation matters.
Executive compensation and say-on-pay
Advisory vote requested to approve named executive officer compensation for fiscal year 2025.
Latest events from Senestech
- New CEO and Board Chair appointed; equity plan amendments and option grants up for shareholder vote.SNES
Proxy filing7 May 2026 - Proxy covers director elections, compensation, equity plan amendment, and auditor ratification.SNES
Proxy filing29 Apr 2026 - E-commerce drove 20% revenue growth, margin gains, and cash runway extends to Q2 2027.SNES
Q4 202512 Mar 2026 - Record revenue and margin gains, but cash constraints require new financing for profitability.SNES
Q2 20241 Feb 2026 - Record growth fueled by innovative fertility control products and expanding global distribution.SNES
Lytham Partners Fall 2024 Investor Conference20 Jan 2026 - Record Q3 revenue and margin gains fueled by Evolve products and e-commerce growth.SNES
Q3 202414 Jan 2026 - Evolve products now drive 70% of sales, fueling rapid growth and improved profitability.SNES
Lytham Partners 2025 Industrials & Basic Materials Investor Summit26 Dec 2025 - Record 70% revenue growth and 61% margin drive progress toward profitability.SNES
Q4 202424 Dec 2025 - Resale of 1.5M+ shares from warrant exercises funds humane rodent control, but financial risk remains.SNES
Registration Filing16 Dec 2025